Antibiotics are not particularly profitable drugs and for a drug company to recoup their investment, an antibiotic must kill as many different bacteria as possible.

In February, the CDC warned that last year, 5% of Shigella infections were “extensively drug-resistant” — meaning they didn’t respond to a number of antibiotics — up from zero percent in ...

Shortages of key medications used to treat common childhood illnesses like flu, ear infections and sore throats are adding to the misery of this year’s early and severe respiratory virus season.

Those drugs include the blood thinner argatroban, the chemotherapy drug bortezomib and antibiotics cefepime, meropenem and vancomycin. You can view a list of the drugs here .

"By mapping the global burden of drug-resistant bacteria and assessing their impact on public health, this list is key to guiding investment and grappling with the antibiotics pipeline and access ...